Global Defibrillators Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 210 pages | ID: GCA266E0067EN
Precision Business Insights (PBI)

Abstracts

Heart muscles require continuous supply of blood for proper functioning. When the supply of blood to the artery is decreased cardiac arrhythmias and heart attack may occur. Blockage of coronary artery may occur due to improper impulse conduction or blood clot. If not treated immediately may lead to death. Defibrillator used to prevent the sudden cardiac attack. Specially used for ventricular fibrillation and non perfusing ventricular tachycardia. These conditions occur due to the disruption of normal electrical impulse that controls the heart rate and pumping action. Defibrillator sends an electrical current to the heart which is used to restart the normal functioning of heart. Defibrillator treatment is given for the patients only when there is a high risk of sudden heart failure or sudden cardiac death. Normally Defibrillator used for outpatient.

Defibrillator market growth is driven by rapidly growing geriatric patients who are very susceptible to cardiac diseases, technological advancements in defibrillators, growing awareness in sudden cardiac arrest, and increased incidents of cardiac diseases. Two of the most important advancements are development of automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). However, factors such as frequent product recalls, increase in pricing pressure on players, and lack of awareness about sudden cardiac arrest (SCA),

• Defibrillator market segmented based on product and end user
• Based on product type, defibrillators market is segmented into Implantable defibrillators and external defibrillators
• Implantable Cardioverter Defibrillators
• Single Chamber Implantable Cardioverter Defibrillator
• Dual Chamber Implantable Cardioverter Defibrillator
• External Defibrillator
• Manual
• Automated
• Wearable

Based on end-user, defibrillator market is segmented into

• Hospitals
• Cardiac Clinics
• Home Care

Many of the heart care associations and alliances are promoting to create awareness about cardiac conditions and to increase the survival rate of the patients are expected to show significant growth for defibrillator market during forecast period.. For instance, in 2016, Global Resuscitation Alliance (GRA) was formed comprising of, global resuscitation leaders, international health organizations and American heart association (AHA). Defibrillator market is very dynamic in nature. Defibrillator market is dominated by very few players. To enhance their sales revenue companies are inorganic growth strategies such as adopting mergers and acquisitions. In addition, companies are betting heavily on R&D to develop new technologies. For instance, in March 2012, Asahi Kasei has acquired ZOLL Medical Corporation for approximately 2.21 Bn to expand their healthcare business globally. In January 2016, Aurora Resurgence, an affiliate of Aurora Capital Group (Los Angeles), a U.S.-based private equity firm acquired the assets of Cardiac Science Corporation. Various defibrillators manufacturers, non-governmental and government organizations installed public access defibrillators (PAD) in private and public places such as airports, malls, and schools in U.S., Australia, Canada, U.K and UAE to increase their adoption. In 2016, 82 automated External defibrillators are installed by The United Arab Emirates government across various locations in the country.

Geographically defibrillator market is segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to major share in defibrillator market mainly due to the well-established healthcare infrastructure and increase in incidence of cardiac diseases and obesity. Furthermore, growing awareness about sudden cardiac arrest and other heart diseases in the U.S. contribute are expected to drive defibrillator growth in North America region. Asia-Pacific region is expected to be fastest growing due to increased obese patients, people with cardiac diseases, rapid development in healthcare infrastructure coupled with increased government spending and public spending on healthcare especially in emerging markets like India and China. Increase in awareness about utility of defibrillators in the Middle-East, especially in U.A.E and the support from government is contributing to growth of defibrillators market in Middle East and Africa region

Some of the players in defibrillator market include Medtronic (U.S.), Abbott Laboratories (U.S.), Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan), LivaNova PLC (U.K), Physio-Control, Inc. (U.S.), Nihon Kohden Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Koninklijke Philips N.V. (Netherlands), and Boston Scientific Corporation(U.S.) to name a few

In July 2016, Life-Assist, Inc. Partnered with Koninklijke Philips N.V. to distribute its automated external defibrillators and patient monitors in the western U.S.

In May 2016 U.S. FDA approved Medtronic's Visia AF single-chamber implantable cardioverter defibrillators for tachycardia management

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL DEFIBRILLATORS MARKET INTRODUCTION

2.1. Global Defibrillators Market– Taxonomy
2.2. Global Defibrillators Market–Definitions
  2.2.1. End User
  2.2.2. Product Type

3. GLOBAL DEFIBRILLATORS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Defibrillators Market Dynamics – Factors Impact Analysis
3.6. Global Defibrillators Market– Recent Market Introductions

4. GLOBAL DEFIBRILLATORS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL DEFIBRILLATORS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Implantable Cardioverter Defibrillators
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. External Defibrillator
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL DEFIBRILLATORS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Hospitals
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Cardiac Clinics
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Home Care
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL DEFIBRILLATORS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. North America
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Region, 2017 – 2023

8. NORTH AMERICA DEFIBRILLATORS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  8.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    8.1.1.1. Implantable Cardioverter Defibrillators
      8.1.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
      8.1.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
    8.1.1.2. External Defibrillator
      8.1.1.2.1. Manual
      8.1.1.2.2. Automated
      8.1.1.2.3. Wearable
  8.1.2. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    8.1.2.1. Hospitals
    8.1.2.2. Cardiac Clinics
    8.1.2.3. Home Care
  8.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    8.1.3.1. U.S.
    8.1.3.2. Canada
  8.1.4. North America Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2017 – 2023
  8.1.5. North America Defibrillators Market Dynamics – Trends

9. EUROPE DEFIBRILLATORS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.1.1. Implantable Cardioverter Defibrillators
      9.1.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
      9.1.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
    9.1.1.2. External Defibrillator
      9.1.1.2.1. Manual
      9.1.1.2.2. Automated
      9.1.1.2.3. Wearable
  9.1.2. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Hospitals
    9.1.2.2. Cardiac Clinics
    9.1.2.3. Home Care
  9.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Germany
    9.1.3.2. UK
    9.1.3.3. France
    9.1.3.4. Spain
    9.1.3.5. Italy
    9.1.3.6. Russia
    9.1.3.7. Poland
    9.1.3.8. Rest of Europe
  9.1.4. Europe Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2017 – 2023
  9.1.5. Europe Defibrillators Market Dynamics – Trends

10. ASIA-PACIFIC DEFIBRILLATORS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.1.1. Implantable Cardioverter Defibrillators
      10.1.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
      10.1.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
    10.1.1.2. External Defibrillator
      10.1.1.2.1. Manual
      10.1.1.2.2. Automated
      10.1.1.2.3. Wearable
  10.1.2. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Hospitals
    10.1.2.2. Cardiac Clinics
    10.1.2.3. Home Care
  10.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    10.1.3.1. Japan
    10.1.3.2. China
    10.1.3.3. India
    10.1.3.4. ASEAN
    10.1.3.5. Australia & New Zealand
    10.1.3.6. Rest of Asia-Pacific
  10.1.4. Asia-Pacific Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2017 – 2023
  10.1.5. Asia-Pacific Defibrillators Market Dynamics – Trends

11. LATIN AMERICA DEFIBRILLATORS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.1.1. Implantable Cardioverter Defibrillators
      11.1.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
      11.1.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
    11.1.1.2. External Defibrillator
      11.1.1.2.1. Manual
      11.1.1.2.2. Automated
      11.1.1.2.3. Wearable
  11.1.2. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Hospitals
    11.1.2.2. Cardiac Clinics
    11.1.2.3. Home Care
  11.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Brazil
    11.1.3.2. Mexico
    11.1.3.3. Argentina
    11.1.3.4. Venezuela
    11.1.3.5. Rest of Latin America
  11.1.4. Latin America Defibrillators Market- Opportunity Analysis Index - By Product Type, End User, and Country, 2017 – 2023
  11.1.5. Latin America Defibrillators Market Dynamics – Trends

12. MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.1.1. Implantable Cardioverter Defibrillators
      12.1.1.1.1. Single Chamber Implantable Cardioverter Defibrillator
      12.1.1.1.2. Dual Chamber Implantable Cardioverter Defibrillator
    12.1.1.2. External Defibrillator
      12.1.1.2.1. Manual
      12.1.1.2.2. Automated
      12.1.1.2.3. Wearable
  12.1.2. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Hospitals
    12.1.2.2. Cardiac Clinics
    12.1.2.3. Home Care
  12.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.3.1. Gulf Cooperation Council (GCC) Countries
    12.1.3.2. Israel
    12.1.3.3. South Africa
    12.1.3.4. Rest of MEA
  12.1.4. MEA Defibrillators Market- Opportunity Analysis Index - By Product Type, By End User, and Country, 2017 – 2023
  12.1.5. MEA Defibrillators Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. Medtronic (U.S.)
  13.2.2. Abbott Laboratories (U.S.)
  13.2.3. Asahi Kasei Corporation (ZOLL Medical Corporation) (Japan)
  13.2.4. LivaNova PLC (U.K)
  13.2.5. Physio-Control, Inc. (U.S.)
  13.2.6. Nihon Kohden Corporation (Japan)
  13.2.7. BIOTRONIK SE & Co. KG (Germany)
  13.2.8. Koninklijke Philips N.V. (Netherlands)
  13.2.9. Boston Scientific Corporation(U.S.)

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS